The issue will comprise only primary share sale
read the full story about PharmEasy parent files for IPO; looks to garner Rs 6,250 crore
#theheadlines #breakingnews #headlinenews #newstoday #latestnews #aajtak #ndtv #timesofindia #indiannews
The issue will comprise only primary share sale
read the full story about PharmEasy parent files for IPO; looks to garner Rs 6,250 crore
#theheadlines #breakingnews #headlinenews #newstoday #latestnews #aajtak #ndtv #timesofindia #indiannews
Copyright © 2024 | WordPress Theme by MH Themes